1-Cyclohexyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 100mg

5-Bromo-2-methoxy-4-methyl-3-nitropyridine, 98.0%, 500g

(2S,3S)-3-Aminobicyclo[2.2.2]octane-2-carboxylic acid hydrochloride, 98%, 5g

(1-((2-(Trimethylsilyl)ethoxy)methyl)-1H-pyrazol-5-yl)boronic acid, 95%, 100mg

3-Bromo-4-chlorofuro[3,2-c]pyridine, 95.0%, 250mg

3-(4-bromophenyl)-5-chloro-1,2-oxazole-4-carbaldehyde, 95.0%, 2g

(E)-1-(4-Methoxyphenyl)-N-(4-((E)-styryl)phenyl)methanimine, 95%, 250mg

Corannulene>97.0%(GC)100mg

N-(2,4-Dimethoxybenzyl)-5-fluoro-N-(6-fluoropyridin-2-yl)-2-oxo-2,3-dihydrobenzo[d]oxazole-6-sulfonamide, 97%, 1g

2-Isopropylaniline, 95.0%, 100g

1-Methoxy-4-[(E)-prop-1-enyl]bicyclo[2.2.2]octane, 98%, 100mg

Pentaérythritol, min 98 %, pour la synthèse, 500 g, emballage plastique.

(2E)-3-[4-(benzyloxy)phenyl]-1-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 2g